Tobias Fritz - Acarix AS Chief Officer

ACARIX Stock

SEK 0.30 0.01 3.23%

Insider

Tobias Fritz is Chief Officer of Acarix AS

Age	44
Phone	46 1 04 71 58 02
Web	https://www.acarix.com

Acarix AS Management Efficiency

The company has return on total asset (ROA) of (0.7996) % which means that it has lost $0.7996 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.458) %, meaning that it generated substantial loss on money invested by shareholders. Acarix AS's management efficiency ratios could be used to measure how well Acarix AS manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Acarix AS to Peers

Predict price of Acarix AS

Acarix AS has accumulated 239 K in total debt with debt to equity ratio (D/E) of 2.3, implying the company greatly relies on financing operations through barrowing. Acarix AS has a current ratio of 7.23, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Acarix AS until it has trouble settling it off, either with new capital or with free cash flow. So, Acarix AS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acarix AS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acarix to invest in growth at high rates of return. When we think about Acarix AS's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Adnan Deronic	Cantargia AB	N/A
	Emanuel Bjrne	Hansa Biopharma AB	50
	Susanne Lagerlund	Cantargia AB	N/A
	Ingrid Teige	BioInvent International AB	N/A
	Oskar Bosson	BioArctic AB	47
	Katja Margell	Hansa Biopharma AB	N/A
	Harald Borgeke	BioArctic AB	N/A
	Peter Madsen	Cantargia AB	N/A
	Kjell Sjstrm	Cantargia AB	N/A
	Sren MSc	Hansa Biopharma AB	58
	Johanna Flting	BioArctic AB	51
	Cecilia Hofvander	BioInvent International AB	56
	Bjrn Frendus	BioInvent International AB	50
	Marcuss	Cantargia AB	N/A
	Pr Lannfelt	BioArctic AB	74
	Christer Mller	BioArctic AB	64
	Klaus Sindahl	Hansa Biopharma AB	N/A
	Jan Mattsson	BioArctic AB	63
	Johanna Christensen	Cantargia AB	N/A
	Gunilla Andersson	BioArctic AB	62
	Gunilla Osswald	BioArctic AB	62

Acarix AB , a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Acarix AB was founded in 2004 and is based in Malm, Sweden. Acarix AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people. Acarix AS (ACARIX) is traded on Stockholm Exchange in Sweden and employs 8 people.

Management Performance

	Return On Equity	-1.46
	Return On Asset	-0.8

Acarix AS Leadership Team

Elected by the shareholders, the Acarix AS's board of directors comprises two types of representatives: Acarix AS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acarix. The board's role is to monitor Acarix AS's management team and ensure that shareholders' interests are well served. Acarix AS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acarix AS's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Christian Lindholm, Chief Officer
	Marianne Norskov, Chief Officer
	Helen Round, Pres CEO
	Thomas Lundstrm, Chief Officer
	Tobias Fritz, Chief Officer
	Anders Krabbe, Chief Officer

Acarix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acarix AS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-1.46
	Return On Asset	-0.8
	Operating Margin	(13.75) %
	Current Valuation	51.77 M
	Shares Outstanding	373.33 M
	Shares Owned By Insiders	10.28 %
	Shares Owned By Institutions	2.84 %
	Price To Book	1.63 X
	Price To Sales	15.38 X
	Revenue	3.76 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Other Information on Investing in Acarix Stock

Acarix AS financial ratios help investors to determine whether Acarix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acarix with respect to the benefits of owning Acarix AS security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC